CompuGroup Medical SE & Co. KGaA (CMPUY) Análisis de Acciones
Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
CMPUY representa a CompuGroup Medical SE & Co. KGaA, una empresa del sector Healthcare con un precio de $ (capitalización de mercado 0). Calificado con 48/100 (cauteloso) en potencial de crecimiento, salud financiera e impulso.
Ultimo analisis: 16 mar 2026CompuGroup Medical SE & Co. KGaA (CMPUY) Resumen de Asistencia Médica y Tuberías
CompuGroup Medical SE & Co. KGaA, a German-based healthcare IT firm, delivers software and IT solutions across four segments: Ambulatory, Pharmacy, Hospital, and Consumer Health. With a global presence and a focus on digital healthcare solutions, the company supports healthcare providers and consumers, holding a significant position in the healthcare information services sector.
Tesis de Inversión
CompuGroup Medical SE & Co. KGaA presents a mixed investment thesis. The company's established presence in the healthcare IT sector and diverse product portfolio across ambulatory, pharmacy, hospital, and consumer health segments provide a stable revenue base. The company's P/E ratio is 89.71, and the profit margin is 1.5%. Growth catalysts include expanding digital health solutions and increasing demand for integrated healthcare systems. Potential risks include intense competition, evolving regulatory landscapes, and the relatively low profit margin. The company's beta of 0.82 suggests lower volatility compared to the market. The dividend yield is 0.22%.
Basado en las finanzas de FMP y el análisis cuantitativo
Puntos clave
- CompuGroup Medical operates in four segments: Ambulatory Information Systems (AIS), Pharmacy Information Systems (PCS), Hospital Information Systems (HIS), and Consumer & Health Management Information Systems (CHS).
- The company serves a global market, providing healthcare IT solutions to various healthcare providers and consumers.
- CompuGroup Medical's gross margin stands at 83.6%, indicating strong pricing power and efficient cost management in its software and IT solutions.
- The company's market capitalization is $1.19 billion, reflecting its significant presence in the healthcare IT sector.
- CompuGroup Medical has a dividend yield of 0.22%, offering a modest income stream for investors.
Competidores y Pares
Fortalezas
- Comprehensive product portfolio across multiple healthcare segments.
- Established presence in the European healthcare IT market.
- Strong gross margin of 83.6%.
- Focus on integrated healthcare solutions.
Debilidades
- Relatively low profit margin of 1.5%.
- Dependence on regulatory compliance and healthcare policies.
- Limited presence in some emerging markets.
- High P/E ratio of 89.71.
Catalizadores
- Ongoing: Increasing adoption of digital health solutions by healthcare providers and consumers.
- Ongoing: Expansion of integrated healthcare systems and data analytics capabilities.
- Upcoming: Potential strategic acquisitions to expand product offerings and market share.
- Ongoing: Government initiatives promoting electronic health records and telehealth services.
- Ongoing: Growing demand for IT security services in the healthcare sector.
Riesgos
- Potential: Intense competition from other healthcare IT providers.
- Potential: Evolving regulatory landscape and compliance requirements.
- Potential: Cybersecurity threats and data breaches.
- Potential: Economic downturns affecting healthcare spending.
- Ongoing: Currency risk associated with the ADR structure.
Oportunidades de crecimiento
- Expansion of Digital Health Solutions: CompuGroup Medical has the opportunity to expand its digital health solutions, including consumer portals and mobile apps. The digital health market is experiencing rapid growth, driven by increasing consumer demand for convenient and accessible healthcare services. By enhancing its digital offerings, CompuGroup Medical can attract new customers and increase revenue. The global digital health market is projected to reach $660 billion by 2025, presenting a substantial growth opportunity for the company.
- Integration of Healthcare Systems: The increasing demand for integrated healthcare systems presents a significant growth opportunity for CompuGroup Medical. Healthcare providers are seeking solutions that can seamlessly integrate data across different systems, improving efficiency and patient care. CompuGroup Medical can capitalize on this trend by developing and offering integrated solutions that connect ambulatory, pharmacy, hospital, and consumer health systems. This integration can lead to increased customer loyalty and higher revenue.
- Geographic Expansion: CompuGroup Medical can pursue geographic expansion to tap into new markets and increase its global presence. Emerging markets, in particular, offer significant growth potential due to increasing healthcare spending and the adoption of digital health technologies. By expanding into these markets, CompuGroup Medical can diversify its revenue streams and reduce its reliance on mature markets. This expansion requires careful market analysis and strategic partnerships to navigate local regulations and cultural differences.
- Strategic Acquisitions: CompuGroup Medical can pursue strategic acquisitions to expand its product portfolio and market share. Acquiring companies with complementary technologies or customer bases can accelerate growth and enhance the company's competitive position. Potential acquisition targets include companies specializing in telehealth, data analytics, or cybersecurity for healthcare providers. These acquisitions should be carefully evaluated to ensure they align with CompuGroup Medical's overall strategy and create synergies.
- Data Analytics and AI: CompuGroup Medical can leverage data analytics and artificial intelligence (AI) to improve its products and services. By analyzing healthcare data, the company can identify trends, predict patient outcomes, and personalize treatment plans. AI can also be used to automate tasks, improve efficiency, and reduce costs. Investing in data analytics and AI capabilities can enhance CompuGroup Medical's competitive advantage and drive innovation in the healthcare IT sector. The market for AI in healthcare is expected to reach $34 billion by 2025.
Oportunidades
- Expansion into new geographic markets.
- Growth in the digital health solutions market.
- Strategic acquisitions to expand product offerings.
- Increased demand for integrated healthcare systems.
Amenazas
- Intense competition from other healthcare IT providers.
- Evolving regulatory landscape and compliance requirements.
- Cybersecurity threats and data breaches.
- Economic downturns affecting healthcare spending.
Ventajas competitivas
- Established Customer Base: Long-standing relationships with a diverse customer base in the healthcare sector.
- Integrated Solutions: Comprehensive suite of integrated software solutions across ambulatory, pharmacy, hospital, and consumer health segments.
- Regulatory Expertise: Deep understanding of healthcare regulations and compliance requirements.
- Data Assets: Proprietary data assets and analytics capabilities that provide valuable insights to customers.
Acerca de CMPUY
CompuGroup Medical SE & Co. KGaA, founded in 1987 and headquartered in Koblenz, Germany, develops and sells software and IT solutions for the healthcare sector globally. The company operates through four key segments: Ambulatory Information Systems (AIS), Pharmacy Information Systems (PCS), Hospital Information Systems (HIS), and Consumer & Health Management Information Systems (CHS). The AIS segment offers practice management software and electronic medical records for physicians and medical centers, along with supplementary internet solutions. The PCS segment provides software applications for pharmacies, focusing on administrative and billing processes, and offers decision support for medication supply chain management. The HIS segment delivers clinical and administrative solutions for hospitals, rehabilitation centers, and medical laboratories. The CHS segment provides IT security services, data-based product offerings, software interfaces, and clinical decision-making support for healthcare providers, as well as digital healthcare platforms and mobile apps for consumers. CompuGroup Medical serves a diverse clientele, including pharmaceutical companies, health insurance companies, and individual consumers. Formerly known as CompuGroup Medical SE, the company rebranded in June 2020 to CompuGroup Medical SE & Co. KGaA, reflecting its continued evolution in the healthcare IT landscape.
Qué hacen
- Develops and sells software for ambulatory information systems (AIS).
- Provides software solutions for pharmacy information systems (PCS).
- Offers clinical and administrative solutions for hospital information systems (HIS).
- Creates consumer and health management information systems (CHS).
- Delivers IT security services for healthcare providers.
- Provides data-based product offers and software interfaces for information sharing.
- Offers clinical decision-making support and medication databases.
- Develops digital healthcare stock, consumer portals, and mobile apps.
Modelo de Negocio
- Software Licensing: Generates revenue through licensing its software solutions to healthcare providers and pharmacies.
- Subscription Services: Offers subscription-based services for ongoing access to its software and related support.
- IT Services: Provides IT security services and data-based product offers to healthcare organizations.
- Data Analytics: Leverages healthcare data to provide insights and analytics to improve patient outcomes and efficiency.
Contexto de la Industria
CompuGroup Medical operates in the rapidly evolving healthcare IT sector. The industry is driven by increasing demand for digital health solutions, electronic health records, and integrated healthcare systems. The market is competitive, with key players including BITGF (Allscripts Healthcare Solutions), BTTAY (Cerner), CSWYF (Change Healthcare), DGWPF (Teladoc Health), and DWRKF (athenahealth). These companies compete on product offerings, technological innovation, and market reach. The healthcare IT market is expected to continue growing, fueled by government initiatives promoting electronic health records and the increasing adoption of telehealth services.
Clientes Clave
- Registered physicians and medical care centers.
- Pharmacies and pharmaceutical companies.
- Acute care hospitals and rehabilitation centers.
- Health insurance companies.
- Consumers seeking digital health solutions.
Finanzas
Gráfico e información
Precio de la acción de CompuGroup Medical SE & Co. KGaA (CMPUY): Price data unavailable
Últimas noticias
No hay noticias recientes disponibles para CMPUY.
Consenso de analistas
Calificación de Consenso
Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para CMPUY.
Objetivos de Precios
Análisis del precio objetivo de Wall Street para CMPUY.
MoonshotScore
¿Qué significa esta puntuación?
El MoonshotScore califica el potencial de crecimiento de CMPUY en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.
Liderazgo: Daniel Gotthardt
Unknown
Information on Daniel Gotthardt's background is not available in the provided data. Therefore, a detailed career history, education, and previous roles cannot be provided. His experience prior to managing 8299 employees at CompuGroup Medical SE & Co. KGaA is Unknown.
Historial: Due to the limited information available, Daniel Gotthardt's key achievements, strategic decisions, and company milestones under his leadership cannot be detailed. His specific contributions to CompuGroup Medical SE & Co. KGaA's performance are Unknown.
Información de ADR de CompuGroup Medical SE & Co. KGaA No patrocinado
An American Depositary Receipt (ADR) is a certificate representing shares of a foreign company trading on U.S. stock exchanges. CMPUY is an ADR representing shares of CompuGroup Medical SE & Co. KGaA, a German company. This allows U.S. investors to invest in the company without directly dealing with foreign exchanges.
- Ticker del mercado local: Frankfurt Stock Exchange, Germany
- Nivel de ADR: 1
- Ratio de ADR: 1:1
- Ticker del mercado local: CMPU
Información del mercado OTC de CMPUY
The OTC Other tier represents the lowest tier of the OTC market, indicating that CompuGroup Medical SE & Co. KGaA has limited regulatory requirements and reporting standards compared to companies listed on major exchanges like the NYSE or NASDAQ. Companies on this tier may not be required to file regular financial reports with the SEC, leading to less transparency for investors. Investing in OTC Other stocks carries higher risks due to the limited information available.
- Nivel OTC: OTC Other
- Estado de divulgación: Unknown
- Limited Transparency: OTC stocks often have limited financial disclosure, making it difficult to assess their true value and financial health.
- Low Liquidity: Trading volumes can be thin, leading to wider bid-ask spreads and difficulty in executing large trades.
- Price Volatility: OTC stocks can be more susceptible to price manipulation and volatility due to lower trading volumes.
- Regulatory Risks: OTC companies may not be subject to the same level of regulatory scrutiny as exchange-listed companies.
- Information Asymmetry: Limited access to information can create an uneven playing field for investors.
- Verify the company's registration and legal status.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team and their track record.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before investing.
- Monitor the company's news and announcements for any updates.
- Established Business Operations: CompuGroup Medical SE & Co. KGaA has been in operation since 1987, indicating a long-standing presence in the healthcare IT sector.
- Global Presence: The company operates worldwide, serving various healthcare providers and consumers.
- Diverse Product Portfolio: CompuGroup Medical offers a comprehensive suite of software and IT solutions across multiple healthcare segments.
- ADR Listing: The existence of an ADR, even at Level I, suggests some level of compliance and oversight.
CMPUY Preguntas Frecuentes sobre Acciones de Healthcare
¿Cuáles son los factores clave para evaluar CMPUY?
CompuGroup Medical SE & Co. KGaA (CMPUY) actualmente tiene una puntuación IA de 48/100, indicando puntuación baja. Fortaleza clave: Comprehensive product portfolio across multiple healthcare segments.. Riesgo principal a monitorear: Potential: Intense competition from other healthcare IT providers.. Esto no es asesoramiento financiero.
¿Qué es el MoonshotScore de CMPUY?
CMPUY actualmente puntúa 48/100 (Grado D) en el MoonshotScore, lo que sugiere calificación baja. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.
¿Con qué frecuencia se actualizan los datos de CMPUY?
Los precios de CMPUY se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.
¿Qué dicen los analistas sobre CMPUY?
La cobertura de analistas para CMPUY incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.
¿Cuáles son los riesgos de invertir en CMPUY?
Las categorías de riesgo para CMPUY incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Intense competition from other healthcare IT providers.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.
¿Cuál es la relación P/E de CMPUY?
La relación P/E para CMPUY compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.
¿Está CMPUY sobrevalorada o infravalorada?
Determinar si CompuGroup Medical SE & Co. KGaA (CMPUY) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.
¿Cuál es el rendimiento por dividendo de CMPUY?
CompuGroup Medical SE & Co. KGaA (CMPUY) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.
Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.
Recursos Oficiales
Datos proporcionados solo con fines informativos.
- Information is based on available data as of 2026-03-16.
- AI analysis pending for CMPUY, which may provide further insights.
- OTC market data may be limited and less reliable than exchange-listed data.